A New York-based biotech company is turning heads on Tuesday after it announced it signed a material transfer agreement to supply SLS-002 for the Department of Defense’s...

To read the full story on AllPennyStocks.com, click here.

Seelos Therapeutics (NASDAQ:SEEL)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024 Plus de graphiques de la Bourse Seelos Therapeutics
Seelos Therapeutics (NASDAQ:SEEL)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024 Plus de graphiques de la Bourse Seelos Therapeutics